Sickle cell bone disease and response to intravenous bisphosphonates in children. Grimbly C, Escagedo PD, Jaremko JL, Bruce A, et al. Osteoporos Int 2022 Jul 29. pii: 10.1007/s00198-022-06455.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Grimbly C, Escagedo PD, Jaremko JL, Bruce A, et al. Sickle cell bone disease and response to intravenous bisphosphonates in children. Osteoporos Int 2022 Jul 29. pii: 10.1007/s00198-022-06455.
PMID: 35904681